Today is Tuesday, February 1st.

We'll tell you about a public face-off between the U.S. and Russia.

Also, COVID-19 vaccine developments, including a new option that may be coming to the U.S.

Plus, where Americans are bracing for another winter storm.

A new owner for the popular game, Wordal.

And today begins the year of the Tiger, how people around the world are celebrating the Lunar New Year.

Welcome, welcome to The Newsworthy, all the days news in around 10 minutes.

Fast, fair, fun, and on the go.

I'm Air Commandy, thanks so much for being here.

You ready?

Let's do this.

The U.S. could soon have a fourth COVID-19 vaccine on the market.

Not a fourth dose, but another vaccine option.

Novavax is the latest company to apply for FDA authorization.

Like the Moderna and Pfizer options, the one from Novavax comes in two shots,

and they're spaced three weeks apart.

But it is made differently, so it could be helpful for people who are allergic to the materials

and other vaccines.

In late-stage trials, the Novavax option was about 90% effective

at preventing COVID-19 cases with symptoms.

And the most common side effects reported were the usual ones we've seen before,

fatigue, headache, and muscle pain.

...